Research Topics
| P BossiSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
[Smallpox, bioterrorism agent]Philippe Bossi
Service de Maladies Infectieuses et Tropicales, Hopital Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris
Presse Med 31:1813-7. 2002..In the case of a bioterrorist attack, the United States and most of the EC countries propose to vaccinate only the health professionnals most exposed to the virus and those having contacted identified cases...
Bichat guidelines for the clinical management of plague and bioterrorism-related plaguePhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E5-6. 2004..For the other clinical types of the disease, patients should be isolated for the first 48 hours after the initiation of treatment...
[Botulism toxin, bioterrorist weapon]Philippe Bossi
Service de maladies infectieuses et tropicales Hôpital Pitié Salpêtrière 47 83 Boulevard de l Hôpital, 75013 Paris
Presse Med 32:463-5. 2003..This vaccine must be administered as rapidly as possible in symptomatic patients. A single case of botulism acquired by inhalation corresponds to an act of terrorism...
Bichat guidelines for the clinical management of smallpox and bioterrorism-related smallpoxPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E7-8. 2004..There is no established antiviral treatment for smallpox. The most effective prevention is vaccination before exposure...
[The plague, possible bioterrorist act]Philippe Bossi
Service de maladies infectieuses et tropicales groupe hospitalier pitié salpêtrière 47 83, Boulevard de l Hopital, 75013 Paris France
Presse Med 32:804-7. 2003..A dead cell vaccine exists, but its efficacy in terms of protection from primary pneumonia appears inadequate...
Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever virusesPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E11-2. 2004..Ribavirin is recommended for the treatment and the prophylaxis of the arenaviruses and the bunyaviruses, but is not effective for the other families. All patients must be isolated and receive intensive supportive therapy...
[Tularemia, a potential bioterrorism weapon]Philippe Bossi
Service de Maladies Infectieuses et Tropicales, Hopital Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris
Presse Med 32:1126-30. 2003..IN GENERAL PRACTICE: Tularemia is a disease that requires official notification. Many guidelines exist for the treatment and prophylaxis of patients having been exposed to F. tularensis...
Bichat guidelines for the clinical management of botulism and bioterrorism-related botulismPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E13-4. 2004..Trivalent equine antitoxins (A,B,E) must be given to patients as soon as possible after clinical diagnosis. Heptavalent human antitoxins (A-G) are available in certain countries...
Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosisPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E15-6. 2004..The combination of ofloxacin plus rifampicin is associated with good results. Even if there is little evidence to support its utility for post-exposure prophylaxis, doxycycline plus rifampicin is recommended for 3 to 6 weeks...
[Severe acute respiratory syndrome: update]P Bossi
Service de Maladies Infectieuses et Tropicales, Hopital de la Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
Rev Med Interne 24:672-80. 2003..In this manuscript, we describe the clinical features, biological findings, virological tests, radiological assessment, outcome and treatments of this infection. FUTURE: Research on specific therapies and vaccines is on-going...
[Q fever, a potential biowarfare agent]Philippe Bossi
Service de Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière Paris 75
Presse Med 32:1618-21. 2003..In fact C. burnetii would more likely be used as a disabling weapon...
Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosisPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E17-8. 2004..Post-exposure prophylaxis with trimethoprim-sulfamethoxazole is recommended in case of a biological attack. There is no vaccine available for humans...
Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthraxPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E3-4. 2004..Treatment consists of massive doses of antibiotics and supportive care. Isolation is not necessary. Antibiotics such as ciprofloxacin are recommended for post-exposure prophylaxis during 60 days...
[Anthrax in the era of biowarfare]Philippe Bossi
Service de maladies infectieuses et tropicales Groupe hospitalier Pitié Salpêtrière, Paris
Presse Med 32:167-73. 2003..Many guidelines have been published with recommendations for the treatment and prophylaxis of anthrax. Prognosis remains poor in the systemic form of the disease...
[Management of therapeutic failure in HIV-infected patients]P Bossi
Service de Maladies Infectieuses et Tropicales, Hopital Pitie Salpetriere, 47 83, Bd de l Hopital, F 75651 Paris
Presse Med 30:806-12. 2001..The possible usefulness of regular drug assays for adjusting treatment doses in case of therapeutic escape remains to be assessed in prospective trials...
Bioterrorism: management of major biological agentsP Bossi
Department of Infectious Diseases, Pitie Salpetriere Hospital, 47 83 Bd de l Hopital, 75013, Paris, France
Cell Mol Life Sci 63:2196-212. 2006..More than 180 pathogens have been reported to be potential agents for bioterrorism. The following is an overview of several agents that could be involved in a biological attack...
[Risk of smallpox, vaccination, bioterrorism]P Bossi
Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier, Pitie Salpetriere, 47 83, Bd de l Hopital, 75013 Paris, France
Presse Med 34:177-184. 2005....
Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q feverPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E19-20. 2004..Nevertheless, treatment can shorten the duration of illness and decrease the risk of complications such as endocarditis. Post-exposure prophylaxis is recommended after the exposure in the case of a bioterrorist attack...
[Diagnosis of sepsis, severe sepsis and septic shock]Philippe Bossi
Service des Maladies Infectieuses et Tropicales, Hopital Pitie Salpetriere, Paris 75
Presse Med 33:262-4; discussion 269. 2004..Genetic susceptibility probably intervenes, genetic variability playing either a protective or a deleterious role (the interest of Toll-like receptors)...
Severe acute disseminated toxoplasmosis acquired by an immunocompetent patient in French GuianaPhilippe Bossi
Department of Infectious Diseases, Pitie Salpetriere Hospital, Paris, France
Scand J Infect Dis 34:311-4. 2002..We report a case of severe acute disseminated toxoplasmosis acquired by an immunocompetent patient in French Guiana and review the literature...
[Emerging or re-emerging infections that can be used for bioterrorism]Philippe Bossi
Service de Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
Presse Med 34:149-55. 2005..INFECTIONS THAT REQUIRE RECOGNITION: The role of practitioners in the rapid recognition of bioterrorism-related infections is crucial. Hence, updated knowledge on these potentially emerging or reemerging infections is required...
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi
Department of Infectious Diseases, Pitie Salpetriere Hospital, 47 83 boulevard de l Hopital, 75013 Paris, France
HIV Med 5:352-9. 2004..To evaluate the benefits of therapeutic drug monitoring (TDM) in association with genotypic resistance testing and expert advice to optimize therapy in multiexperienced patients infected with HIV-1...
Bichat clinical guidelines for bioterrorist agentsPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E1-2. 2004
Bichat guidelines for the clinical management of viral encephalitis and bioterrorism-related viral encephalitisPhilippe Bossi
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E21-2. 2004..There is no effective drug therapy for the treatment of these diseases and treatment is mainly supportive, but vaccines protecting against some of these viruses do exist...
[Epidemiological features and incidence trends of primary cerebral lymphomas observed in 80 HIV-infected patients from 1983 to 1999]A Rigolet
Services de Maladies Infectieuses et Tropicales, , 47-83, , 75651 Paris, France
Pathol Biol (Paris) 49:572-5. 2001..CONCLUSION: After the introduction of HAART (1996), the incidence of PCNSL has decreased drastically and survival was increased...
[Glanders, melioidosis and biowarfare]Amélie Guilhot
Service de maladies infectieuses et tropicales Hôpital Pitié Salpêtrière, 47 83, Boulevard de l Hopital, 75013 Paris, France
Presse Med 34:185-8. 2005..We have to consider these agents as possible biological warfare agents. Europeans guidelines for treatment and post-exposure prophylaxis are detailed...
[Lymph-node tuberculosis in patients infected or not with HIV: general characteristics, clinical presentation, microbiological diagnosis and treatment]P Hochedez
Service de Maladies Infectieuses et Tropicales, , 47-83, , 75013 Paris, France
Pathol Biol (Paris) 51:496-502. 2003..Three HIV infected patients were infected by mycobacteria resistant to at least one antibiotic (isoniazid, 1; rifampicin, 1; isoniazid, streptomycin, etambutool, 1). All the patients recovered...
Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemiaPhilippe Bossi
Taskforce on Bioterrorism (BICHAT, Public Health Directorate, European Commission, Luxembourg
Euro Surveill 9:E9-10. 2004..Quinolone is an effective alternative drug. No isolation measures for patients with pneumonia are necessary. Streptomycin, gentamicin, doxycycline or ciprofloxacin are recommended for post-exposure prophylaxis...
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAnne Genevieve Marcelin
Department of Virology, INSERM EMI 0214, Bichat Claude Bernard Hospital, Paris, France
Antimicrob Agents Chemother 47:594-600. 2003....
[Acute viral meningitis. Epidemiologic, clinical and biological characteristics of 29 hospitalized patients]D Sene
Service de Maladies Infectieuses et Tropicales, Hopital Pitie Salpetriere, 47 83 Bd de l Hopital, F75651 Paris
Presse Med 31:254-8. 2002
[Vaccinal strategies against smallpox in France]F Bricaire
Service de Maladies Infectieuses et Tropicales, , 47-83, , 75013 Paris, France
Med Mal Infect 34:1-5. 2004
Toxoplasma gondii-associated Guillain-Barré syndrome in an immunocompetent patientP Bossi
Departments of Infectious Diseases, Pitie Salpetriere Hospital, Paris, France
J Clin Microbiol 36:3724-5. 1998..The patient's condition improved with pyrimethamine and sulfadiazine. Only the standard treatment for toxoplasmosis was effective, whereas intravenous immunoglobulins were ineffective...
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitorsP Bossi
Department of Virology, Pitie Salpetriere Hospital, 47 83 Bd de l Hopital, Paris, France
HIV Med 4:67-71. 2003..P-gps have been detected on peripheral CD4 blood cells in HIV-1-infected, but antiretroviral-naive patients...
[Bioterrorism and health security in the European Union]Georgios Gouvras
Public Health Directorate, JMO C3 32, European Commission, L 2920 Luxembourg
Presse Med 34:156-60. 2005....
[Current clinical aspects of HIV/AIDS]V Zeller
Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, F75013 Paris
Presse Med 31:74-9. 2002..At present, heterosexuality is the most frequent risk factor for HIV-infection (51%). Pneumocystis pneumonia remains the most common opportunistic illness in HIV-infected patients (28%)...
Medication misuse in hospitalized patients with renal impairmentL Salomon
University Hospital Pitié Salpêtrière AP HP, Paris VI, Public Health Department, Paris, France
Int J Qual Health Care 15:331-5. 2003..The purpose of this study was to determine the frequency and potential consequences of a lack of dosage adjustment in hospitalized patients with renal impairment...
[Haemorrhagic fever viruses, possible bioterrorist use]Sophie Rigaudeau
Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
Presse Med 34:169-76. 2005..Except for yellow fever, there is no vaccination for the other forms of viral haemorrhagic fever...
Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitisValerie Zeller
Service des Maladies Infectieuses et Tropicales, CHU Pitie Salpetriere, 75651 Paris Cedex 013, France
Clin Infect Dis 34:662-7. 2002....
Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovirMyrto Astriti
Department of Infectious Diseases, , , 75651 Paris Cedex 13, France
J Infect 52:237-42. 2006..We describe the case of a patient infected with HIV and a concomitant HHV-6 encephalitis. The patient experienced virological failure following cidofovir treatment. RT-PCR was used both for early diagnosis and follow-up...
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recoveryJade Ghosn
Departement des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire Pitié Paris, France
Clin Infect Dis 37:e112-4. 2003..This atypical recurrence was more likely to be a reinfection than a reactivation, as attested by the genotypic analysis of the Toxoplasma gondii strain recovered from the patient...
[Viral encephalitis virus, a new bioterrorist menace]Sophie Rigaudeau
Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris, France
Presse Med 34:161-8. 2005..The aim of terrorist groups who would use this type of weapon is more to provoke panic and disorganisation than to kill as many people as possible...
Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistanceAna Canestri
Department des Maladies Infectieuses, , Paris, France
Antivir Ther 11:561-6. 2006..CONCLUSION: In patients with HIV mutations conferring resistance to all antiretroviral drug classes, foscarnet markedly reduced plasma HIV load and improved immunological status...
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patientsAnne Genevieve Marcelin
Department of Virology, Pitie Salpetriere Hospital, Paris, France
J Med Virol 74:16-20. 2004..There was no relation between the resistance pathways selected with either APV or ritonavir plasma minimal concentration, but higher APV plasma minimal concentration were associated with a lower rate of resistance mutations selection...
Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivoC Manichanh
Laboratoire de Virologie, UPRES EA 2387, CERVI, , , 75651 Paris Cedex 13, France
J Gen Virol 82:2767-76. 2001..These findings provide strong circumstantial evidence that the M(318)V change of the PK gene is associated with resistance to GCV and raise the question of cross resistance to this drug among different betaherpesviruses...
[Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers]Francois Bricaire
Service des Maladies Infectieuses et Tropicales, G H Pitié Salpêtrière, 47 83 boulevard de l Hopital, 75013 Paris
Bull Acad Natl Med 190:1035-46; discussion 1046-9. 2006..Three-quarters of the subjects had a proliferative response. This response was lower after the age of 55 years but could be reactivated by revaccination...
Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcomaAmelie Guihot
Laboratoire d'Immunologie Cellulaire et Tissulaire du Pr. Debre, INSERM UMR S 543, Batiment CERVI, Hopital Pitie-Salpetriere, 47 Bd de l'Hopital, 75013, Paris, France
J Infect Dis 194:1078-88. 2006..Also, we have described 8 new HHV-8 T cell epitopes in LANA-1, K12, and K15, including 2 CD4 T cell epitopes. These data provide new insight into HHV-8 cellular immunity...
Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteersPhilippe Bossi
Department of Infectious Diseases, University Pierre and Marie Curie, Paris VI, Paris, France
PLoS ONE 3:e4087. 2008..This program included the establishment of a preoutbreak national team that could be revaccinated against smallpox...
Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART eraCaroline Charlier
Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA 3012, Institut Pasteur, Paris, France
PLoS ONE 3:e1950. 2008..Given this, we suggest that investigation for cryptococcosis-related lesions is merited, even in the absence of neurological abnormality, if a high fungal burden is suspected on the basis of high serum and/or CSF antigen titers...
Cytokine pattern in Kaposi's sarcoma associated with immune restoration disease in HIV and tuberculosis co-infected patientsJerome Tamburini
Department of Infectious Diseases, Pitie Salpetriere Hospital, Paris, France
AIDS 21:1980-3. 2007..Analysis of VEGF and pro-inflammatory cytokines led us to hypothesize that Kaposi's sarcoma could be promoted by the tuberculosis immune response...
Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humansBénédicte Puissant-Lubrano
INSERM U945, Paris, France
J Clin Invest 120:1636-44. 2010....
Acute bacterial meningitis in a patient receiving ibuprofenJerome Tamburini
Department of Infectious Diseases, Pitie Salpetriere Hospital, 47 83 boulevard de l Hopital, 75651 Paris, Cedex 13 France
J Infect 51:336-7. 2005..Anti-inflammatory therapy such as NSAIDs could reduce CSF inflammation and modify the clinical outcome in patients with bacterial meningitis. However, the use of NSAIDs is not recommended in bacterial meningitis due to a lack of studies...
The European Commission's Task Force on BioterrorismAnders Tegnell
Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, L-2920 Luxembourg, Belgium
Emerg Infect Dis 9:1330-2. 2003
[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia]Amelie Guihot
Service de Maladies Infectieuses et Tropicales, Hopital Pitie Salpetriere, Paris
Presse Med 33:344-51. 2004..The reservoir of the virus, which may be animal, is still unknown. The epidemic seems to be controlled, but sporadic or epidemic re-emergences may occur and have been observed in China during January 2004...
Chikungunya infection in travelersPatrick Hochedez
, Paris, France
Emerg Infect Dis 12:1565-7. 2006..We describe the manifestations of chikungunya virus infection in travelers returning from these islands, with focus on skin manifestations...
[Rickettsioses]Jade Ghosn
Service des Maladies Infectieuses et Tropicales, , 75651 Paris Cedex 13
Rev Prat 55:707-12. 2005..Travellers to endemic areas should be encouraged to use personal protective measures...
[Herpes simplex virus meningitis in 11 patients]Charles Binetruy
Département de Maladies Infectieuses et Tropicales, Hopital Pitie Salpetriere, Paris, France
Med Mal Infect 38:141-5. 2008..We reviewed retrospectively the demographic, clinical, biological characteristics and outcomes of 11 patients with HSV meningitis...
Lung cancer in patients with HIV Infection and review of the literatureJean Philippe Spano
Pitie Salpetriere Hospital, Department of Medical Oncology, bld de I Hopital, 75013 Paris, France
Med Oncol 21:109-15. 2004..The improved survival of patients since the use of highly active antiretroviral treatments has lead to the reporting of non-AIDS defining tumors, such as lung cancer...
Severe acute disseminated toxoplasmosisPhilippe Bossi
Lancet 364:579. 2004
[Treatment of severe sepsis and septic shock]David Grimaldi
Service des Maladies Infectieuses et Tropicales, , Paris (75
Presse Med 33:265-8; discussion 269. 2004..Intensive insulin therapy is aimed at maintaining normal glycemia in the patients for as long as possible...
[Emerging viral diseases]Francois Bricaire
Service des Maladies infectieuses et tropicales Groupe Hospitalier de la Pitié Salpêtrière, 47 Bld de l Hopital, 75015 Paris
Bull Acad Natl Med 190:597-608; discussion 609, 625-7. 2006..Pox and Monkeypox are "virtually emerging" viruses that have potential for use in bioterrorism. The management and treatment of these emerging infectious diseases calls for new approaches, organizations and infrastructures...
Stevens-Johnson syndrome associated with abacavir therapyPhilippe Bossi
Clin Infect Dis 35:902. 2002
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational studyCristina Mussini
Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy
Clin Infect Dis 38:565-71. 2004..Recurrent cryptococcal infection should be suspected in patients whose serum cryptococcal antigen test results revert back to positive after discontinuation of maintenance therapy...
[Antiretroviral-induced toxiderma in HIV-infected patients]Eric Caumes
Service des Maladies Infectieuses et Tropicales, , Paris (75
Presse Med 32:1325-33. 2003..The practical approach varies depending on the drug responsible, the clinical form of the toxiderma and the possible alternatives...
[HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma]Jean Gabarre
, , 47, , 75013 Paris
Bull Cancer 90:419-25. 2003..The administration of chemotherapy with HAART does not seem to increase toxicity...
HHV-6 variant A meningoencephalitis after allogeneic hematopoietic stem cell transplantation diagnosed by quantitative real-time polymerase chain reactionAdrienne de Labarthe
Transplantation 80:539. 2005
[Infectious agents as terrorism weapons]Philippe Bossi
Presse Med 34:147-8. 2005
High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitorsPhilippe Bossi
AIDS 17:1108-10. 2003
[Physiopathology of severe sepsis]Vincent Caille
, , Boulogne Billancourt (92
Presse Med 33:256-61; discussion 269. 2004....
Upper urinary tract infection as a leading cause of fever among female travelers returning from the tropicsValerie Zeller
Department of Infectious and Tropical Diseases, Hopital Pitie Salpetriere, 47 83 boulevard de l Hopital, 75651 Paris Cedex 013, France
J Travel Med 10:139-40. 2003
[Bioterrorism with brucellosis]Amelie Guihot
Service de maladies infectieuses et tropicales Hôpital Pitié Salpêtrière, Paris 75
Presse Med 33:119-22. 2004..However, the morbidity of this agent should not be underrated since it leads to chronic and disabling pathologies...
Thoracic radiographic and CT findings of multicentric Castleman disease in HIV-infected patientsAmelie Guihot
Service de Pneumologie, Hopital Foch, Suresnes, France
J Thorac Imaging 22:207-11. 2007..In this pictorial essay, we describe different thoracic imaging of MCD, with particular emphasis on computed tomography findings, in 13 HIV-infected patients with histologically proved MCD...
Pneumonia among travelers returning from abroadSéverine Ansart
Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitie Salpetriere, Paris, France
J Travel Med 11:87-91. 2004....
